Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Human Serum Albumin was estimated at US$ 5110 million in the year 2022, is projected to reach a revised size of US$ 8369 million by 2029, growing at a CAGR of 7.27 % during the forecast period 2023-2029.
North American market for Human Serum Albumin was valued at $ 651 million in 2022, will reach $ 986 million by 2029, at a CAGR of 6.07% during the forecast period of 2023 through 2029.
Asia-Pacific market for Human Serum Albumin was valued at $ 3507 million in 2022, will reach $ 5896 million by 2029, at a CAGR of 7.71 % during the forecast period of 2023 through 2029.
Europe market for Human Serum Albumin was valued at $ 729 million in 2022, will reach $ 1113 million by 2029, at a CAGR of 6.11 % during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Serum Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Serum Albumin.
The Human Serum Albumin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Human Serum Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Serum Albumin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
Market Segmentation
This report covers the Human Serum Albumin segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2018-2022, 2023-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
By Company
- Grifols
- CSL
- Takeda
- Octapharma
- CBPO
- Hualan Bio
- Kedrion
- Shanghai RAAS
- LFB Group
- Biotest
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
Segment by Type
- 5% Concentrations
- 20-25% Concentrations
Segment by Application
- Excipient
- Therapeutics
- Other
By Region
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Southeast Asia
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- South America
- Brazil
Core Chapters
- Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
- Chapter Two: Detailed analysis of Human Serum Albumin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
- Chapter Three: Sales, revenue of Human Serum Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
- Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
- Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
- Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter Twelve: Analysis of sales channel, distributors and customers.
- Chapter Thirteen: Research Findings and Conclusion.
Table of Contents
1 Human Serum Albumin Market Overview
- 1.1 Human Serum Albumin Product Overview
- 1.2 Human Serum Albumin Market by Type
- 1.2.1 5% Concentrations
- 1.2.2 20-25% Concentrations
- 1.3 Global Human Serum Albumin Market Size by Type
- 1.3.1 Global Human Serum Albumin Market Size Overview by Type (2018-2029)
- 1.3.2 Global Human Serum Albumin Historic Market Size Review by Type (2018-2023)
- 1.3.3 Global Human Serum Albumin Forecasted Market Size by Type (2024-2029)
- 1.4 Key Regions Market Size by Type
- 1.4.1 North America Human Serum Albumin Sales Breakdown by Type (2018-2023)
- 1.4.2 Europe Human Serum Albumin Sales Breakdown by Type (2018-2023)
- 1.4.3 Asia-Pacific Human Serum Albumin Sales Breakdown by Type (2018-2023)
- 1.4.4 South America Human Serum Albumin Sales Breakdown by Type (2018-2023)
- 1.4.5 Middle East and Africa Human Serum Albumin Sales Breakdown by Type (2018-2023)
2 Human Serum Albumin Market Competition by Company
- 2.1 Global Top Players by Human Serum Albumin Sales (2018-2023)
- 2.2 Global Top Players by Human Serum Albumin Revenue (2018-2023)
- 2.3 Global Top Players by Human Serum Albumin Price (2018-2023)
- 2.4 Global Top Manufacturers Human Serum Albumin Manufacturing Base Distribution, Sales Area, Product Type
- 2.5 Human Serum Albumin Market Competitive Situation and Trends
- 2.5.1 Human Serum Albumin Market Concentration Rate (2018-2023)
- 2.5.2 Global 5 and 10 Largest Manufacturers by Human Serum Albumin Revenue in 2022
- 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Serum Albumin as of 2022)
- 2.7 Founded Date of Key Human Serum Albumin Manufacturer
- 2.8 Mergers & Acquisitions, Expansion
3 Human Serum Albumin Status and Outlook by Region
- 3.1 Global Human Serum Albumin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
- 3.2 Global Human Serum Albumin Historic Market Size by Region
- 3.2.1 Global Human Serum Albumin Sales in Volume by Region (2018-2023)
- 3.2.2 Global Human Serum Albumin Sales in Value by Region (2018-2023)
- 3.2.3 Global Human Serum Albumin Sales (Volume & Value), Price and Gross Margin (2018-2023)
- 3.3 Global Human Serum Albumin Forecasted Market Size by Region
- 3.3.1 Global Human Serum Albumin Sales in Volume by Region (2024-2029)
- 3.3.2 Global Human Serum Albumin Sales in Value by Region (2024-2029)
- 3.3.3 Global Human Serum Albumin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Human Serum Albumin by Application
- 4.1 Human Serum Albumin Market by Application
- 4.1.1 Excipient
- 4.1.2 Therapeutics
- 4.2 Global Human Serum Albumin Market Size by Application
- 4.2.1 Global Human Serum Albumin Market Size Overview by Application (2018-2029)
- 4.2.2 Global Human Serum Albumin Historic Market Size Review by Application (2018-2023)
- 4.2.3 Global Human Serum Albumin Forecasted Market Size by Application (2024-2029)
- 4.3 Key Regions Market Size by Application
- 4.3.1 North America Human Serum Albumin Sales Breakdown by Application (2018-2023)
- 4.3.2 Europe Human Serum Albumin Sales Breakdown by Application (2018-2023)
- 4.3.3 Asia-Pacific Human Serum Albumin Sales Breakdown by Application (2018-2023)
- 4.3.4 South America Human Serum Albumin Sales Breakdown by Application (2018-2023)
- 4.3.5 Middle East and Africa Human Serum Albumin Sales Breakdown by Application (2018-2023)
5 North America Human Serum Albumin by Country
- 5.1 North America Human Serum Albumin Historic Market Size by Country
- 5.1.1 North America Human Serum Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
- 5.1.2 North America Human Serum Albumin Sales in Volume by Country (2018-2023)
- 5.1.3 North America Human Serum Albumin Sales in Value by Country (2018-2023)
- 5.2 North America Human Serum Albumin Forecasted Market Size by Country
- 5.2.1 North America Human Serum Albumin Sales in Volume by Country (2024-2029)
- 5.2.2 North America Human Serum Albumin Sales in Value by Country (2024-2029)
6 Europe Human Serum Albumin by Country
- 6.1 Europe Human Serum Albumin Historic Market Size by Country
- 6.1.1 Europe Human Serum Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
- 6.1.2 Europe Human Serum Albumin Sales in Volume by Country (2018-2023)
- 6.1.3 Europe Human Serum Albumin Sales in Value by Country (2018-2023)
- 6.2 Europe Human Serum Albumin Forecasted Market Size by Country
- 6.2.1 Europe Human Serum Albumin Sales in Volume by Country (2024-2029)
- 6.2.2 Europe Human Serum Albumin Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Serum Albumin by Region
- 7.1 Asia-Pacific Human Serum Albumin Historic Market Size by Region
- 7.1.1 Asia-Pacific Human Serum Albumin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
- 7.1.2 Asia-Pacific Human Serum Albumin Sales in Volume by Region (2018-2023)
- 7.1.3 Asia-Pacific Human Serum Albumin Sales in Value by Region (2018-2023)
- 7.2 Asia-Pacific Human Serum Albumin Forecasted Market Size by Region
- 7.2.1 Asia-Pacific Human Serum Albumin Sales in Volume by Region (2024-2029)
- 7.2.2 Asia-Pacific Human Serum Albumin Sales in Value by Region (2024-2029)
8 South America Human Serum Albumin by Country
- 8.1 South America Human Serum Albumin Historic Market Size by Country
- 8.1.1 South America Human Serum Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
- 8.1.2 South America Human Serum Albumin Sales in Volume by Country (2018-2023)
- 8.1.3 South America Human Serum Albumin Sales in Value by Country (2018-2023)
- 8.2 South America Human Serum Albumin Forecasted Market Size by Country
- 8.2.1 South America Human Serum Albumin Sales in Volume by Country (2024-2029)
- 8.2.2 South America Human Serum Albumin Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Serum Albumin by Country
- 9.1 Middle East and Africa Human Serum Albumin Historic Market Size by Country
- 9.1.1 Middle East and Africa Human Serum Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
- 9.1.2 Middle East and Africa Human Serum Albumin Sales in Volume by Country (2018-2023)
- 9.1.3 Middle East and Africa Human Serum Albumin Sales in Value by Country (2018-2023)
- 9.2 Middle East and Africa Human Serum Albumin Forecasted Market Size by Country
- 9.2.1 Middle East and Africa Human Serum Albumin Sales in Volume by Country (2024-2029)
- 9.2.2 Middle East and Africa Human Serum Albumin Sales in Value by Country (2024-2029)
10 Company Profiles
- 10.1 Grifols
- 10.1.1 Grifols Company Information
- 10.1.2 Grifols Introduction and Business Overview
- 10.1.3 Grifols Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 10.1.4 Grifols Human Serum Albumin Products Offered
- 10.1.5 Grifols Recent Development
- 10.2 CSL
- 10.2.1 CSL Company Information
- 10.2.2 CSL Introduction and Business Overview
- 10.2.3 CSL Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 10.2.4 CSL Human Serum Albumin Products Offered
- 10.2.5 CSL Recent Development
- 10.3 Takeda
- 10.3.1 Takeda Company Information
- 10.3.2 Takeda Introduction and Business Overview
- 10.3.3 Takeda Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 10.3.4 Takeda Human Serum Albumin Products Offered
- 10.3.5 Takeda Recent Development
- 10.4 Octapharma
- 10.4.1 Octapharma Company Information
- 10.4.2 Octapharma Introduction and Business Overview
- 10.4.3 Octapharma Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 10.4.4 Octapharma Human Serum Albumin Products Offered
- 10.4.5 Octapharma Recent Development
- 10.5 CBPO
- 10.5.1 CBPO Company Information
- 10.5.2 CBPO Introduction and Business Overview
- 10.5.3 CBPO Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 10.5.4 CBPO Human Serum Albumin Products Offered
- 10.5.5 CBPO Recent Development
- 10.6 Hualan Bio
- 10.6.1 Hualan Bio Company Information
- 10.6.2 Hualan Bio Introduction and Business Overview
- 10.6.3 Hualan Bio Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 10.6.4 Hualan Bio Human Serum Albumin Products Offered
- 10.7 Kedrion
- 10.7.1 Kedrion Company Information
- 10.7.2 Kedrion Introduction and Business Overview
- 10.7.3 Kedrion Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 10.7.4 Kedrion Human Serum Albumin Products Offered
- 10.8 Shanghai RAAS
- 10.8.1 Shanghai RAAS Company Information
- 10.8.2 Shanghai RAAS Introduction and Business Overview
- 10.8.3 Shanghai RAAS Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 10.8.4 Shanghai RAAS Human Serum Albumin Products Offered
- 10.8.5 Shanghai RAAS Recent Development
- 10.9 LFB Group
- 10.9.1 LFB Group Company Information
- 10.9.2 LFB Group Introduction and Business Overview
- 10.9.3 LFB Group Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 10.9.4 LFB Group Human Serum Albumin Products Offered
- 10.10 Biotest
- 10.10.1 Biotest Company Information
- 10.10.2 Biotest Introduction and Business Overview
- 10.10.3 Biotest Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 10.10.4 Biotest Human Serum Albumin Products Offered
- 10.11 Tiantan Bio
- 10.11.1 Tiantan Bio Corporation Information
- 10.11.2 Tiantan Bio Main Business Overview
- 10.11.3 Tiantan Bio Human Serum Albumin Products Offered
- 10.11.4 Tiantan Bio Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 10.12 Shuanglin Bio
- 10.12.1 Shuanglin Bio Corporation Information
- 10.12.2 Shuanglin Bio Main Business Overview
- 10.12.3 Shuanglin Bio Human Serum Albumin Products Offered
- 10.12.4 Shuanglin Bio Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 10.13 Boya Bio
- 10.13.1 Boya Bio Corporation Information
- 10.13.2 Boya Bio Main Business Overview
- 10.13.3 Boya Bio Human Serum Albumin Products Offered
- 10.13.4 Boya Bio Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 10.14 Yuanda Shuyang
- 10.14.1 Yuanda Shuyang Corporation Information
- 10.14.2 Yuanda Shuyang Main Business Overview
- 10.14.3 Yuanda Shuyang Human Serum Albumin Products Offered
- 10.14.4 Yuanda Shuyang Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 10.15 Weiguang Bio
- 10.15.1 Weiguang Bio Corporation Information
- 10.15.2 Weiguang Bio Main Business Overview
- 10.15.3 Weiguang Bio Human Serum Albumin Products Offered
- 10.15.4 Weiguang Bio Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
- 11.1 Human Serum Albumin Key Raw Materials
- 11.1.1 Key Raw Materials
- 11.1.2 Raw Materials Key Suppliers
- 11.2 Manufacturing Cost Structure
- 11.2.1 Raw Materials
- 11.2.2 Labor Cost
- 11.2.3 Manufacturing Expenses
- 11.3 Human Serum Albumin Industrial Chain Analysis
- 11.4 Human Serum Albumin Market Dynamics
- 11.4.1 Human Serum Albumin Industry Trends
- 11.4.2 Human Serum Albumin Market Drivers
- 11.4.3 Human Serum Albumin Market Challenges
- 11.4.4 Human Serum Albumin Market Restraints
12 Marketing Strategy Analysis, Distributors
- 12.1 Sales Channel
- 12.2 Human Serum Albumin Distributors
- 12.3 Human Serum Albumin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
- 14.3 Disclaimer